Approval · Notice of Compliance 9464 · 2008
VECTIBIX: Notice of Compliance 9464
Issued April 3, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 9464
- Date
- April 3, 2008
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic
- With conditions
- Yes (NOC/c)
Products in this notice
Medicinal ingredients
- PANITUMUMAB 100 MG per 5ML
- PANITUMUMAB 200 MG per 10ML
- PANITUMUMAB 400 MG per 20ML